Media ReleasesAuscann Group Holdings

View All Auscann Group Holdings News

AusCann Announces Chilean Cultivation Licence Secured for Second Crop

• AusCann’s 50:50 joint venture in Chile, DayaCann, has secured its second cultivation licence

• Licence allows the JV to commence cultivation activities immediately at its facility in Chile

• This is the only licence granted in Chile to cultivate medical cannabis

• Chile represents a significant market, with a large patient population, supportive regulatory framework for medical cannabis companies and wider access to Latin America

• Follows the successful harvest of the JV’s first crop in Chile earlier this year of over 400kg

• Provides further support for the JV to become fully integrated across the full spectrum of the Latin America medicinal cannabis supply chain

AusCann Group Holdings Ltd (ASX:AC8 or ‘the Company’) is pleased to announce that its joint venture (JV) in Chile, DayaCann, has secured a further licence for the cultivation of medical cannabis crops at its Chilean facility.

For further information please download PDF attached:
Download this document